Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients

A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Patient Aged 5-Year Old or Younger in Outpatient Department

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00660114

Acronym

PUL NIS

Enrollment

914

Registered

2008-04-17

Start date

2008-04-30

Completion date

2009-03-31

Last updated

2009-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough Variant Asthma

Keywords

Cough variant asthma, Pulmicort® Respules®, Chinese patient Eligibility

Brief summary

This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 5 Years

Healthy volunteers

Inclusion criteria

* Provision of informed consent * Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study. * The usage of Pulmicort® Respules® follows local authorised package insert.

Exclusion criteria

* Allergy to any ingredient of Pulmicort® Respules® * With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan. * Have used systemic/inhaled steroid prior to 2 weeks of recruitment

Design outcomes

Primary

Measure	Time frame
Patient Symptom Score	7 weeks (plus or minus 3 days )

Secondary

Measure	Time frame
Patient Compliance Report	7 weeks (plus or minus 3 days )
Investigator Assessment Report	7 weeks (plus or minus 3 days )

Countries

China

Outcome results